Ipilimumab-induced colonic perforation

Biologic immune modulators such as ipilimumab have demonstrated the efficacy against metastatic melanoma. We present a recent case of a 52-year-old male who initially developed mild colitis following the initiation of ipilimumab treatment for metastatic melanoma. Despite initial improvement with imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Burdine, Lyle, Lai, Keith, Laryea, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197918/
https://www.ncbi.nlm.nih.gov/pubmed/24876393
http://dx.doi.org/10.1093/jscr/rju010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197918/
https://www.ncbi.nlm.nih.gov/pubmed/24876393
http://dx.doi.org/10.1093/jscr/rju010

Ejemplares similares